Page last updated: 2024-09-04

ag 3-5 and Absence Seizure

ag 3-5 has been researched along with Absence Seizure in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allen, JR; Bartberger, MD; Biswas, K; Brown, J; Chen, JJ; Clarine, J; Davis, CD; Gavva, NR; Gore, VK; Harried, S; Horne, DB; Horner, M; Kaller, MR; Lehto, SG; Liu, Q; Ma, VV; Monenschein, H; Nguyen, TT; Youngblood, BD; Yuan, CC; Zhang, M; Zhong, W	1

Other Studies

1 other study(ies) available for ag 3-5 and Absence Seizure

Article	Year
Discovery of TRPM8 Antagonist ( S)-6-(((3-Fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin-2-yl)methyl)carbamoyl)nicotinic Acid (AMG 333), a Clinical Candidate for the Treatment of Migraine. Journal of medicinal chemistry, 2018, 09-27, Volume: 61, Issue:18 Topics: Animals; Anticonvulsants; Calcium Channel Agonists; Drug Discovery; Humans; Male; Microsomes, Liver; Migraine Disorders; Models, Molecular; Molecular Structure; Niacin; Pyrimidinones; Rats; Rats, Sprague-Dawley; Seizures; TRPM Cation Channels	2018

Article

Year

Discovery of TRPM8 Antagonist ( S)-6-(((3-Fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin-2-yl)methyl)carbamoyl)nicotinic Acid (AMG 333), a Clinical Candidate for the Treatment of Migraine.

Journal of medicinal chemistry, 2018, 09-27, Volume: 61, Issue:18

Topics: Animals; Anticonvulsants; Calcium Channel Agonists; Drug Discovery; Humans; Male; Microsomes, Liver; Migraine Disorders; Models, Molecular; Molecular Structure; Niacin; Pyrimidinones; Rats; Rats, Sprague-Dawley; Seizures; TRPM Cation Channels

2018